Understanding the Assumptions on Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis. (PubMed, Clin Pharmacol Ther) - Sep 24, 2026 - No abstract available
Journal • P3 data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|